HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Infant Formula Production Stalls On Reckitt Benckiser's Latest Stumble

This article was originally published in The Rose Sheet

Executive Summary

A "technical problem" interrupted infant formula production at firm's Netherlands plant during third quarter, causing a 8% dive in its revenues from Enfamil and other brand formulas. The problem has been corrected but revenues will be slowed during the current quarter and likely into early 2019.  But analysts say the imapct could be deeper impact because it's the fourth problems since 2011 RB should have avoided.

Advertisement

Related Content

Reckitt Boosts 2018 Guidance A Year After Gaining China Platform With MJN
Reckitt At '2.0' On Nutrition Market Expansion But Question No. 1 Remains, Potential Pfizer Consumer Bid?
Schiff Supplements, MJN Formulas, Other Reckitt Benckiser Consumer Brands Get Their Own Home
RB Says Petya Cyberattack Froze Shipments, Could Cost £100M

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

RS122409

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel